Literature DB >> 7607737

Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.

L Chen1, J R McNeill, T W Wilson, V Gopalakrishnan.   

Abstract

We compared the role of endothelium and of endothelin in mediating the vasoconstrictor responses to angiotensin II (Ang II) in three vascular smooth muscle preparations--aorta, mesenteric artery, and tail artery--isolated from adult male Sprague-Dawley rats. The vasoconstrictor potency for Ang II in blood vessels with endothelium varied in the following rank order: aorta > mesenteric artery > tail artery. Although the maximal tension responses to Ang II were similar for mesenteric and tail arteries, it was significantly lower in aorta. Endothelium removal led to a leftward shift in the concentration-response curves to Ang II in the aorta but a rightward shift in the mesenteric artery. Strikingly, Ang II failed to evoke tension responses in tail artery in the absence of endothelium. The endothelin-A (ETA)-selective antagonist BQ-123 blocked the responses to Ang II in a noncompetitive manner, with partial and complete attenuation of responses in the endothelium-intact mesenteric and tail artery preparations, respectively. In contrast, BQ-123 did not affect the responses to Ang II in the aorta. BQ-123 also failed to affect the responses to Ang II in endothelium-denuded mesenteric artery rings. The Ang II type 1 (AT1) receptor-selective antagonist losartan competitively blocked the responses to Ang II in the three tissues (pA2, 8.3 to 8.7) when endothelium was present. These data suggest that there are endothelium-dependent regional variations in vascular tissue sensitivity to Ang II.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607737     DOI: 10.1161/01.hyp.26.1.83

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Prenatal protein restriction leads to a disparity between aortic and peripheral blood pressure in Wistar male offspring.

Authors:  Angelina Swali; Sarah McMullen; Simon C Langley-Evans
Journal:  J Physiol       Date:  2010-08-06       Impact factor: 5.182

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Endothelin mediates some of the renal actions of acutely administered angiotensin II.

Authors:  A Riggleman; J Harvey; C Baylis
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

5.  Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.

Authors:  R R Wenzel; J Rüthemann; H Bruck; R F Schäfers; M C Michel; T Philipp
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

7.  Lack of involvement of endothelin-1 in angiotensin II-induced contraction of the isolated rat tail artery.

Authors:  Y Jiang; C R Triggle
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

8.  Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries.

Authors:  R S Garcha; P S Sever; A D Hughes
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

9.  Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta.

Authors:  Q Li; L Zhang; M Pfaffendorf; P A van Zwieten
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.

Authors:  Li Yao; Hiroyuki Kobori; Matlubur Rahman; Dale M Seth; Takatomi Shokoji; Yuyan Fan; Guo-Xing Zhang; Shoji Kimura; Youichi Abe; Akira Nishiyama
Journal:  Hypertens Res       Date:  2004-07       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.